Strata Critical Medical (NASDAQ:SRTA – Get Free Report) CAO Amir Cohen sold 4,655 shares of the firm’s stock in a transaction on Monday, June 8th. The shares were sold at an average price of $5.87, for a total transaction of $27,324.85. Following the completion of the transaction, the chief accounting officer directly owned 146,608 shares in the company, valued at $860,588.96. This trade represents a 3.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Amir Cohen also recently made the following trade(s):
- On Friday, May 22nd, Amir Cohen sold 40,575 shares of Strata Critical Medical stock. The shares were sold at an average price of $5.91, for a total transaction of $239,798.25.
- On Thursday, May 21st, Amir Cohen sold 10,300 shares of Strata Critical Medical stock. The shares were sold at an average price of $5.79, for a total transaction of $59,637.00.
Strata Critical Medical Stock Performance
Shares of SRTA stock opened at $5.43 on Friday. The firm has a 50-day moving average price of $5.22. The stock has a market capitalization of $469.86 million, a P/E ratio of -67.88 and a beta of 2.20. Strata Critical Medical has a one year low of $3.57 and a one year high of $6.50.
Analyst Ratings Changes
Several equities analysts have recently weighed in on the stock. Weiss Ratings upgraded shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, May 11th. B. Riley Financial assumed coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They issued a “buy” rating and a $8.00 target price for the company. Craig Hallum assumed coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They issued a “buy” rating and a $8.00 target price for the company. Finally, Zacks Research upgraded shares of Strata Critical Medical to a “hold” rating in a research note on Thursday, March 26th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $8.00.
View Our Latest Stock Analysis on Strata Critical Medical
Institutional Investors Weigh In On Strata Critical Medical
Several hedge funds have recently bought and sold shares of SRTA. Granite Investment Partners LLC lifted its holdings in shares of Strata Critical Medical by 77.0% in the 1st quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock worth $76,000 after acquiring an additional 7,911 shares during the last quarter. Seelaus Asset Management LLC lifted its holdings in shares of Strata Critical Medical by 32.7% in the 1st quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock worth $102,000 after acquiring an additional 6,000 shares during the last quarter. Principal Financial Group Inc. bought a new stake in shares of Strata Critical Medical in the 1st quarter worth approximately $537,000. Quantinno Capital Management LP lifted its holdings in shares of Strata Critical Medical by 98.7% in the 1st quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock worth $599,000 after acquiring an additional 71,155 shares during the last quarter. Finally, Bank of America Corp DE lifted its holdings in shares of Strata Critical Medical by 16.2% in the 1st quarter. Bank of America Corp DE now owns 181,574 shares of the company’s stock worth $759,000 after acquiring an additional 25,379 shares during the last quarter. 47.36% of the stock is currently owned by institutional investors.
Strata Critical Medical Company Profile
Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.
Featured Articles
- Five stocks we like better than Strata Critical Medical
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Strata Critical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Critical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
